Enrolling

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor…

This is a study to evaluate the efficacy and safety of AZD0780 in adults with clinical ASCVD or who are at risk for a first ASCVD event and…

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to…

The Transform trial is utilizing CCTA technology to develop a plaque staging software system for asymptomatic individuals at increased risk…

This trial is looking at the medication Omecamtiv Mecarbil (OM for short) in patients with severely reduced ejection fraction (pumping…

The purpose of this study is to investigate the effect of balcinrenone/dapagliflozin compared with dapagliflozin, on the risk of CV death…

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a…

THARROS is the first-ever prospective trial to investigate the potential of an inhaled triple therapy to reduce cardiopulmonary events, a…

This study will be done to see if ziltivekimab can be used to treat people living with heart failure and inflammation. Participants will…

The purpose of this study is to evaluate the efficacy of the medication JTT-861 administered for 12 weeks in subjects with heart failure…

The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and…